Remarkably, intratumoral injection of the BCP/PLGA-PEG-PLGA composites into the tumor notably hindered tumor expansion compared to BSA-PTX, demonstrating sustained drug release within the tumor region. The gene discussed is OPN1SW; the disease is neoplasm.